The DOI matches its Crossref record.
Treatment of E. Coli and Klebsiella Bacteremia in Agranulocytic Animals with Antiserum to a UDP-GAL Epimerase-Deficient Mutant
Abstract
In order to produce antiserum with broad protection against different Gramnegative bacteria we immunized rabbits with a UDP-galactose-deficient mutant (J5) of Escherichia coli O111 that is unencumbered by O antigen since it cannot incorporate galactose into core LPS. Without O side chains, core is accessible for producing antiserum to a wide range of bacteria with similar cores. Such antiserum has previously been shown to prevent unrelated endotoxins from producing dermal and generalized Shwartzman reactions, and death. The current study reports the results of treating bacteremia with this antiserum. Bacteremia was produced in rabbits made granulocytopenic with nitrogen mustard and fed either Klebsiella pneumoniae, E. coli O17 (multiply antibiotic-resistant), or E. coli O4. Since most rabbits are coliform-free, the organisms colonized the gut and overwhelming bacteremia occurred as granulocytes disappeared. When nonimmune serum was given intravenously (i.v.) at the onset of bacteremia with any of these three organisms, only 3.1% to 5.7% survived. In contrast, survival rates in animals given antiserum to the J5 mutant were 33.3% from E. coli O4, 40% from Klebsiella, and 69.2% from the multiply antibiotic-resistant E. coli O17 (combined p < 0.0005). Antiserum to the parent E. coli O111, (with O antigen intact) provided no significant protection. The protection against death from E. coli O17 by J5 antiserum was greater than that obtained from gentamicin (50%), the only antibiotic to which this strain was sensitive. Rabbits given J5 antiserum cleared labeled bacteria more rapidly than those given nonimmune sera. Antiserum to the J5 mutant is thought to prevent lethal bacteremia from unrelated Gram-negative bacteria by acting as both antitoxin and opsonin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a Mutant Escherichia coli
Ziegler, E. J., McCutchan, J. A., Fierer, J., Glauser, M. P., Sadoff, J. C., Douglas, H., & Braude, A. I. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211113072001 · Cited by 1,046
Self-citationInterleukin-1 receptor antagonist reduces mortality from endotoxin shock
Ohlsson, K., Björk, P., Bergenfeldt, M., Hageman, R., & Thompson, R. C. (1990) · Nature · doi:10.1038/348550a0 · Cited by 853
Bacterial Endotoxins and Host Immune Responses
Morrison, D. C., & Ryan, J. L. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60802-0 · Cited by 613
Rietschel, E. T., Brade, H., Holst, O., Brade, L., Müller-Loennies, S., Mamat, U., Zähringer, U., Beckmann, F., Seydel, U., Brandenburg, K., et al. (1996) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-80186-0_3 · Cited by 469
Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of Pathogenesis
Natanson, C., Hoffman, W. D., Suffredini, A. F., Eichacker, P. Q., & Danner, R. L. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-9-199405010-00009 · Cited by 442
Baumgartner, J.-D., Mccutchan, J. A., Van Melle, G., Vogt, M., Luethy, R., Glauser, M., Ziegler, E., Klauber, M., Muehlen, E., Chiolero, R., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90176-x · Cited by 375
Self-citationCalandra, T., Glauser, M. P., Schellekens, J., & Verhoef, J. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/158.2.312 · Cited by 263
Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine.
(1989) · Europe PMC (PubMed Central) · Cited by 109
Field trial to determine efficacy of an Escherichia coli J5 mastitis vaccine
Hogan, J. S., Smith, K. L., Todhunter, D. A., & Schoenberger, P. S. (1992) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(92)77741-8 · Cited by 96
Immunity targeting common core antigens of Gram-negative bacteria
Tyler, J. W., Cullor, J. S., Spier, S. J., & Smith, B. P. (1990) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1990.tb00870.x · Cited by 33
Metadata
- Authors
- Ziegler, E. J., Douglas, H., Sherman, J. E., Davis, C. E., & Braude, A. I.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1973-08-01
- Volume
- 111
- Issue
- 2
- Pages
- 433-438
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1952804450
- Cited by
- 216
- References
- 0
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.